Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104765 · ClinicalTrials.gov registry record · Phase 1
A Study of LY2951742 in Healthy Japanese and Caucasian Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT02104765 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 45 participants.
The verdict
NCT02104765, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The main purpose of this study is to evaluate the safety of the study drug known as LY2951742 in healthy Japanese and Caucasians. The study will also investigate how the body processes the drug and how the drug affects the body. The study is expected to last about 5 to 7 months, depending on the arm.
Interventions
- DRUG Placebo
- DRUG LY2951742
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02104765
The ClinicalTrials.gov registry entry for NCT02104765 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02104765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02104765 about?
NCT02104765 is a clinical study titled "A Study of LY2951742 in Healthy Japanese and Caucasian Participants". The main purpose of this study is to evaluate the safety of the study drug known as LY2951742 in healthy Japanese and Caucasians. The study will also investigate how the body processes the drug and how the drug affects the body. The study is expected to last about 5 to 7 months, depending on the arm...
What is the current status of trial NCT02104765?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2014-06. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02104765?
The interventions under investigation include: Placebo (DRUG), LY2951742 (DRUG).
Who is sponsoring clinical trial NCT02104765?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.